Aesthetic Injectables | Market Insights | Asia Pacific | 2022
Although the COVID-19 pandemic will have a significant impact on the Asia Pacific aesthetic injectable market in the short term, the market will grow rapidly through 2030. Recovery of the market will depend on a number of factors, including pace of vaccine distribution in the region. Patients returning for maintenance procedures, growing virtual interaction leading to the “Zoom Effect”, an expanding patient pool from emerging patient groups such as men and younger individuals, and the overall cost-effectiveness of these procedures over surgical options will be the major drivers in the market.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aesthetic injectables (including BTX and dermal fillers) in the Asia Pacific region across an 11-year period.
